Exosomes derived from miR-338-3p-modified adipose stem cells inhibited inflammation injury of chondrocytes via targeting RUNX2 in osteoarthritis

Abstract

Background Osteoarthritis (OA) is a chronic degenerative disease that is one of the main causes of disability in middle-aged and elderly people. Adipose stem cell (ASC)-derived exosomes (ASC-Exo) could repair cartilage damage and treat OA. MiRNA-338-3p expression was confirmed to play a role in inhibiting proinflammatory cytokines. Herein, we aimed to explore the mechanism by which exosomes derived from miR-338-3p overexpressing ASCs protects chondrocytes from interleukin (IL)-1β-induced chondrocyte change. Methods Exosomes were extracted from ASCs transfected with miR-338-3p or its antisense inhibitor. The ASC-Exos (miR-338-3p silencing/overexpression) were incubated with IL-1β-induced ATDC5 cells, followed by evaluation of the chondrocyte proliferation, degradation, and inflammation injury. Results In vitro results revealed that ASC-Exos inhibited the expression of prostaglandin E2 (PGE2), IL-6, IL-1β, and TNF-α, as well as promoted the proliferation of ATDC5 cells. Moreover, ASC-Exos inhibited inflammation injury and degradation of ATDC5 cells by transferring miR-338-3p. Luciferase reporter assays showed that RUNX2 was a target gene of miR-338-3p. Additionally, RUNX2 overexpression in ATDC5 cells reversed the protective effect of miR-338-3p on chondrocytes. Taken together, this study demonstrated that exosomes secreted from miR-338-3p-modified ASCs were effective in the repair of IL-1β-induced chondrocyte change by inhibiting RUNX2 expression. Conclusions Our result provided valuable data for understanding the mechanism of ASC-Exos in OA treatment. Graphical abstract

Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis

“…Furthermore, BMMSC-Exos, delivering the lncRNA LYRM4-AS1, modulated the viability of IL-1β-induced chondrocytes via the LYRM4-AS1/GRPR/miR-6515-5p axis ( Wang et al, 2021 ). Another study confirmed that human umbilical cord-derived MSCs exosomes (UCMSC-Exos) could effectively promote chondrocytes proliferation and migration ( Li et al, 2022 ). It was reported that MSC-Exos derived from embryonic stem cell (ESCMSC-Exos) promoted the proliferation and migration of chondrocytes without affecting matrix synthesis through adenosine-mediated activation of AKT and ERK signaling pathways ( Zhang et al, 2018 ).…”

Strategies in product engineering of mesenchymal stem cell-derived exosomes: unveiling the mechanisms underpinning the promotive effects of mesenchymal stem cell-derived exosomes

“…The encapsulated miR-338-3p within these exosomes is delivered to interleukin-1β-induced ADTC5 cells, promoting the degradation of RUNX2 mRNA. Consequently, this results in the inhibition of cell degradation and apoptosis, alongside the promotion of cell proliferation ( Li et al, 2022 ).Wu Jiangyi et al demonstrated that exosomes secreted by infrapatellar fat pad MSCs can maintain cartilage homeostasis by enhancing autophagy levels, attributed to the inhibition of mTOR. The encapsulated miR-100-5p within these exosomes can bind to the 3′-untranslated region (3′UTR) of mTOR, promoting its degradation.…”

Adipose-Derived Mesenchymal Stromal Cells in Basic Research and Clinical Applications

“…In response to treatment with the aforementioned agents, miR155, miR150, and miR 146a remained elevated for at least five days. This suggests that miRNAs are mediators of short-term memory in immune cells as well as MSCs [ 102 ].…”